Full name
OMC CLINICAL RESEARCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
21.2 - Manufacture of medicines and other pharmaceutical products
70.2 - Management consultancy activities
72 - Scientific research and development
73.2 - Market research and public opinion polling
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | ||||
Gross profit (loss) | -41,2 | 0 | 0 | 0 |
EBITDA | -41,2 | 0 | 0 | 0 |
Short time liabilities | 94,8 | 80 | 80 | 0 |
Other operating costs | ||||
Equity capital | -77,6 | -77,6 | -77,6 | 0 |
Operating profit (EBIT) | -41,2 | 0 | 0 | 0 |
Assets | 17,3 | 2,4 | 2,4 | 0 |
Net profit (loss) | -41,2 | 0 | 0 | 0 |
Cash | 0,3 | 2,4 | 2,4 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 94,8 | 80 | 80 | 0 |
Working assets | 17,3 | 2,4 | 2,4 | 0 |
Other income costs | ||||
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 53,2 | 0 | 0 | 0 |
Equity capital to total assets | -449,1 | -3166,3 | -3166,3 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.18211276829242706 | 0.03061549924314022 | 0.03061549924314022 | 0 |
Net dept to EBITDA | 0.00771751906722784 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane